Neuroprotective effect of lipoxin A4 methyl ester in a rat model of permanent focal cerebral ischemia

J Mol Neurosci. 2010 Oct;42(2):226-34. doi: 10.1007/s12031-010-9355-8. Epub 2010 Apr 17.

Abstract

Neuroprotective effect of lipoxin A(4) methyl ester (LXA(4) ME) was tested in a rat model of permanent middle cerebral artery occlusion. LXA(4) ME was administrated through intracerebroventricular injection immediately after middle cerebral artery was occluded. Administration of LXA(4) ME ameliorated neurological deficit, reduced infarct volume, attenuated histological damage, and decreased number of apoptotic neuron induced by ischemic insult. These neuroprotective effects of LXA(4) ME were associated with inhibition of neutrophil infiltration, lipid peroxidation, and astrocyte activation. In addition, LXA(4) ME also attenuated proinflammatory cytokines (TNF-alpha and IL-1beta) production. These data suggest that LXA(4) ME protects neuron against permanent cerebral ischemia by inhibiting inflammatory responses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytes / drug effects
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / immunology
  • Brain Ischemia / pathology
  • Cerebral Infarction / drug therapy
  • Cerebral Infarction / immunology
  • Cerebral Infarction / pathology
  • Disease Models, Animal
  • Encephalitis / drug therapy
  • Encephalitis / immunology
  • Encephalitis / pathology
  • Esters / pharmacology*
  • Injections, Intraventricular
  • Lipid Peroxidation / drug effects
  • Lipoxins / administration & dosage*
  • Male
  • Neuroprotective Agents / administration & dosage*
  • Neutrophils / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Recovery of Function / drug effects

Substances

  • Esters
  • Lipoxins
  • Neuroprotective Agents
  • lipoxin A4